AJM Theme Issue: CardiologyAJM online: Clinical research studyNational Trends in Outcomes Among Elderly Patients with Heart Failure
Section snippets
Study Cohort
The study sample was derived from the Centers for Medicare and Medicaid Services’ administrative records and included all fee-for-service Medicare beneficiaries aged 65 years or more who were hospitalized with heart failure in acute care facilities between 1992 and 1999. Cohorts were identified for each calendar year from the Centers for Medicare and Medicaid Services’ Inpatient Standard Analytic Files using International Classification of Diseases, Ninth Revision, Clinical Modification
Results
The demographic characteristics of the patients did not change substantially during the study period (1992-1999 [age 79.3-79.9 years; female, 57.3%-59.1%; white, 85.9%-84.5%]). We found a considerable increase, however, in the proportion of patients with comorbidities such as diabetes (26.2%-36.7%), hypertension (26.6%-44.4%), and dementia (2.8%-5.0%). The proportion of patients with a Deyo comorbidity score of 3 or more also increased from 14.2% to 30.7% (Table 1).
Crude rates of
Major Findings
In this analysis of national administrative Medicare data, we demonstrate that overall, little progress was made in improving outcomes for elderly patients hospitalized with heart failure during the 1990s. Specifically, there has been no change in short-term mortality and only minor improvement in long-term mortality, whereas short-term hospital readmission rates have increased.
Although these results contrast remarkably with the 20% to 30% relative reduction in mortality and the 30% to 40%
Prior studies of temporal trends in heart failure survival and hospital readmission
The results of several studies that examined recent trends in heart failure outcomes have been conflicting. Prospective cohort-based data from both the Framingham Heart Study and the Rochester Epidemiology Project have demonstrated improvements in long-term heart failure survival during the 1990s compared with the period from 1950 to 1969 and 1979 to 1984, respectively.18, 19 However, those studies predominantly contrasted mortality during the 1990s with that of earlier decades and did not
Translating medical progress into practice
The lack of substantial improvement in outcomes seen in our study underscores the complexity of applying medical progress to actual practice. Future efforts to improve outcomes in elderly patients with heart failure will likely need to be directed toward several key objectives: improving use of and adherence to lifesaving therapies in patients who are eligible to receive them, generating knowledge about appropriate therapies in patients with heart failure with preserved systolic function, and
Summary
Despite significant advances in heart failure management, our results show a lack of substantial improvement in outcomes among elderly patients hospitalized with this condition during the 1990s. These data underscore the complexity of translating medical progress into clinical practice and emphasize the importance of coordinated efforts designed to improve outcomes in this patient group.
References (41)
The neurohormonal hypothesisa theory to explain the mechanism of disease progression in heart failure
J Am Coll Cardiol
(1992)- et al.
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunctiona systematic overview of data from individual patients
Lancet
(2000) - et al.
Effect of beta-blockade on mortality in patients with heart failurea meta-analysis of randomized clinical trials
J Am Coll Cardiol
(1997) - et al.
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
Lancet
(1993) - et al.
Mortality trends for 23,505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991 to 1997
Am Heart J
(2003) - et al.
Trends in heart failure outcomes and pharmacotherapy1992 to 2000
Am J Med
(2004) - et al.
Confirmation of a heart failure epidemicfindings from the Resource Utilization Among Congestive Heart Failure (REACH) study
J Am Coll Cardiol
(2002) - et al.
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
J Clin Epidemiol
(1992) - et al.
Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure
Am Heart J
(2003) - et al.
Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure
J Am Coll Cardiol
(2003)
Importance of heart failure with preserved systolic function in patients > or = 65 years of age. Cardiovascular Health Study
Am J Cardiol
Gender, age, and heart failure with preserved left ventricular systolic function
J Am Coll Cardiol
The underutilization of cardiac medications of proven benefit, 1990 to 2002
J Am Coll Cardiol
Time trends in the use of beta-blockers and other pharmacotherapies in older adults with congestive heart failure
Am Heart J
Nonadherence with angiotensin-converting enzyme inhibitor therapya comparison of different ways of measuring it in patients with chronic heart failure
J Am Coll Cardiol
The neurohumoral axis in congestive heart failure
Ann Intern Med
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
N Engl J Med
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
N Engl J Med
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
N Engl J Med
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
N Engl J Med
Cited by (80)
Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019
2022, JACC: Heart FailureHeart failure education in the emergency department markedly reduces readmissions in un- and under-insured patients
2018, American Journal of Emergency MedicineMultimorbidity and acute heart failure in internal medicine
2017, International Journal of CardiologyMicroparticles in Chronic Heart Failure
2017, Advances in Clinical ChemistryHeart Failure: A Primer
2015, Critical Care Nursing Clinics of North AmericaCitation Excerpt :Only 50% of patients live for 5 years after the diagnosis of HF,11 and those living with HF experience significant symptom burden, functional limitations,12 and decreased health-related quality of life (HRQOL).13 Thus, despite decades of advances in therapeutics and knowledge of HF pathogenesis,14 there are considerable opportunities to reduce both the national and personal burdens of HF.15 This article reviews the definition, common causal and pathogenic mechanisms, diagnosis, and treatment of chronic HF.
Biomarkers: Cardiovascular Biomarkers: Translational Aspects of Hypertension, Atherosclerosis, and Heart Failure in Drug Development
2015, Principles of Translational Science in Medicine: From Bench to Bedside: Second Edition
This publication was supported by grant number 1 K01 DP000085-01 from the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.
The Centers for Medicare and Medicaid Services (CMS) reviewed and approved the use of its data for this work, and approved submission of the manuscript; this approval is based on data use only, and does not represent a CMS endorsement of or comment on the manuscript content.
Neither CDC nor CMS played a role in the design and conduct of the study, or in the analysis and interpretation of the data. All authors had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the analysis.
- 1
Dr. Kosiborod was a fellow in the Robert Wood Johnson Clinical Scholars Program at Yale University School of Medicine during the time this work was conducted.